financetom
Business
financetom
/
Business
/
PotlatchDeltic Fiscal Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PotlatchDeltic Fiscal Q3 Adjusted Earnings, Revenue Rise
Nov 3, 2025 2:55 PM

05:41 PM EST, 11/03/2025 (MT Newswires) -- PotlatchDeltic ( PCH ) reported fiscal Q3 adjusted net income late Monday of $0.36 per diluted share, up from $0.04 a year earlier.

Analysts polled by FactSet expected $0.17.

Revenue for the quarter ended Sept. 30 was $314.2 million, up from $255.1 million a year earlier.

Analysts expected $296.9 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Planet Labs Signs Contract With Farmdar to Provide Agriculture Insights
Planet Labs Signs Contract With Farmdar to Provide Agriculture Insights
Jul 8, 2025
10:11 AM EDT, 07/08/2025 (MT Newswires) -- Planet Labs (PL) said Tuesday it signed a new six-figure contract with Farmdar, giving the agriculture technology company access to Planet's deep archive of data. Planet's satellite imagery will provide insights agricultural operations, aiding in precise crop detection, arable land mapping, among others, said Planet Labs. Shares of the company rose 2.5% in...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Jul 8, 2025
...
Niagen Bioscience, Norway's Haukeland University Hospital Sign Agreement to Develop Parkinson's Therapy
Niagen Bioscience, Norway's Haukeland University Hospital Sign Agreement to Develop Parkinson's Therapy
Jul 8, 2025
10:03 AM EDT, 07/08/2025 (MT Newswires) -- Niagen Bioscience ( NAGE ) said Tuesday it has signed an agreement with Norway's Haukeland University Hospital, securing exclusive rights to a body of proprietary intellectual property and data to develop its nicotinamide adenine dinucleotide coenzyme, or NAD+, patented as Nicotinamide Riboside, and branded as Niagen, as a potential therapy for Parkinson's Disease....
Copyright 2023-2026 - www.financetom.com All Rights Reserved